Pulse Explore Journal Club Debates Trending Researchers Journals

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Research Paper | Synapse

February 2, 2026Future Oncology0 citations

View Full Paper

Prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer: a retrospective cohort study

FCFurkan CeylanBilkent University SSSerhat SekmekBilkent University ATAteş Kutay TenekeciHacettepe University

Key Points

To evaluate the prognostic value of the glucose-to-lymphocyte ratio in patients with surgically treated endometrial cancer.
Conducted a retrospective cohort study
Analyzed glucose-to-lymphocyte ratio in relation to outcomes
Assessed disease-free survival rates among participants
Found that the glucose-to-lymphocyte ratio is an independent prognostic factor for disease-free survival
Indicated that lower ratios correlate with better survival rates

Abstract

GLR is an independent prognostic factor for DFS in endometrial cancer and may serve as a readily available, cost-effective biomarker. Further prospective studies are needed for validation.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Ceylan et al. (Wed,) studied this question.

synapsesocial.com/papers/6980fbe1c1c9540dea80dad4 https://doi.org/https://doi.org/10.1080/14796694.2026.2622299

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Sentinel node mapping in endometrial cancer2023 · 50 citations
2Diabetes and cancer2009 · 1,012 citations
3Prognostic Significance of the Immune Microenvironment in Endometrial Cancer2024 · 6 citations
4Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells2018 · 81 citations
5Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer2024 · 3 citations